Global Topical Drug Delivery Market Estimated to Reach USD 205.1 Billion by 2024
BAYER AG AND VALEANT PHARMACEUTICALS INTERNATIONAL, INC. ARE DOMINATING THE MARKET FOR GLOBAL TOPICAL DRUG DELIVERY MARKET IN 2016
Global Topical Drug Delivery Market: Segmentation
Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World)
Drivers included Topical Drug Delivery Market:
Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.
Ask for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market
Rising Cases of Acute and Chronic Diseases
The prevalence of diseases and conditions such as infections which includes bacterial infection and fungal infections, inflammations, pain management, acne, sun burns, psoriasis, dermatitis, skin allergy, skin cancer, diabetes, and many others has increased considerably over a period of time.
Rising Aging Population
With the increasing age, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, allergy, arthritis, infections, and dermatitis.
Technological Advancements and Innovations
With the rising prevalence of acute and chronic diseases it has become important for the drug and device manufacturers to develop advanced technologies that will provide more effective treatment for the diseases. In the few years, many developments took place for the topical drug delivery due to the rapid absorption of drugs.
Approval of New Drugs
With the increasing demand for the treatment of diseases using painless and non-invasive method the demand for topical drug delivery is increasing.
Better Opportunity in Pharmerging Markets
According to Data Bridge Market Research analysts, Japan, Europe and North America are expected to account for around 73% of total global pharmaceutical market, while the rest of the world only own 27% of the market.
Inquiry about this Report visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market
Major Key Players Included in Topical Drug Delivery Market:
The major players in the topical drug delivery prescription drugs are
• Galderma Pharma, S.A.,
• Allergen Plc. Kaken Pharmaceuticals, Co., Ltd,
• Bayer AG,
• Hisamitsu Pharmaceuticals, Co., Inc.,
• Abbvie, Inc.,
• Valeant Pharmaceuticals,
• Antares Pharma
• Among others.
The global topical drug delivery market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Other players in this market include Allergen Plc. Kaken Pharmaceuticals, Co., Ltd, Pfizer, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc., Antares Pharma among others. Some of the other players in the global topical drug delivery market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., and Solvay among others.
Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science.
• On July 2015, the U.S. Food and Drug Administration (FDA) approved Finacea Foam, for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
Valeant Pharmaceuticals International, Inc.
• Founded in 1994 and headquartered in Quebec, Canada, Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics.
In August 2016, Valeant announced the re-launch of its generic ofloxacin otic solution to treat bacterial ear infections. The product was temporarily discontinued in April 2015 due to an issue concerning the active pharmaceutical ingredient supplier, which has been resolved.
Read more about this Report visit @ http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market/
Table of Content:
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
7. TOPICAL DRUG DELIVERY MARKET, BY END-USER
8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.2. CRESCITA THERAPEUTICS
11.3. GALDERMA S.A.
11.4. BIOFARMITALIA S.R.L
11.5. PHARMATEK LABORATORIES, INC.
11.6. STIEFEL LABORATORIES, INC.
11.8. NITTO DENKO CORPORATION
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.9. MYLAN PHARMACEUTICALS INC.
11.9. HISAMITSU PHARMACEUTICAL CO., INC.
11.10. THERASOLVE NV.
11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.12. LOHMANN THERAPIE-SYSTEME AG
11.13. PROSOLLUS PHARMACEUTICALS
11.14. EASTON PHARMACEUTICALS INC.
11.15. ANTARES PHARMA, INC.
11.16. ENDO PHARMACEUTICALS INC.
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.20. 3M DRUG DELIVERY SYSTEMS
North America Contraceptive Devices Market – Industry Trends and Forecast to 2024
North America Contraceptive Devices Market, By Product Type, By End-User, By Distribution Channel, By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/north-america-contraceptive-devices-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Topical Drug Delivery Market Estimated to Reach USD 205.1 Billion by 2024 here
News-ID: 711219 • Views: 201
More Releases from Data Bridge Market Research
Seafood Processing Equipment Market Status Analysis and Forecast 2026 By ARCOS L …
Global Seafood Processing Equipment Market is expected to rise from its initial estimated value of USD 2.03 billion in 2018 to an estimated value of USD 2.68 billion by 2026, registering a CAGR of 3.51% in the forecast period of 2019-2026. Increase in the demand for the healthy food is the major factor for the growth of this market. seafood processing equipment market report comprises of historic data along with future
Flow Chemistry Market Forecast Until 2026 By CEM Corporation, Syrris Ltd, Vapour …
A DBMR team uses simple language and easy to understand statistical images to provide thorough information and in-depth data on the chemical industry and flow chemistry market. The company profiles of all the key players and brands that are dominating the market have been taken into consideration here. The report also shares gross margin, market share, attractiveness index, and value and volume growth of all of the segments studied by
Fintech Block Chain Market Forecasts 2019 to 2025: By AWS, IBM, Microsoft, Rippl …
Global Fintech Block Chain Market accounted for USD 232.0 billion in 2017 and is projected to grow at a CAGR of 76.2% the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The fintech block chain report explains market analysis based on regional, local as well as global level.
Well Intervention Market 2019:Dynamics and Development By Schlumberger Limited, …
Global Well Intervention Market is expected to rise from its initial estimated value of USD 8.75 billion in 2018 to an estimated value of USD 13.37 billion by 2026, registering a CAGR of 5.45% in the forecast period of 2019-2026. Increasing demand for energy is the major factor driving the growth of this market. The report covers several topics including market trend analysis, market drivers, market restraints, opportunities, threats, application analysis,
More Releases for Pharma
Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business